What Provider Organizations Are Eligible For 340B Drug Pricing Benefits?: An OPEN MINDS Market Intelligence Report

Created in 1992, the federal 340B Drug Pricing Program (340B Program), which is overseen by the federal Health Resources and Services Administration (HRSA), allows qualified provider organizations to purchase outpatient drugs at a discounted price in order to provide more individuals with care and “stretch scare federal resources.” The cost of the drug discount is born by the pharmaceutical manufacturers as a stipulation of participating in Medicaid programs. Although the purpose of the discount is to be able to provide drugs to more consumers, 340B organizations are not required to pass the discount along to consumers and may use any . . .